Paper38278784
Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice.
Dos Santos Alves RP and 21 others. Nat Commun, 2024. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice. Papers, record 38278784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38278784
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Coronavirus OC43, Human | Major topic |
| Humans | |
| Mice | |
| Animals | |
| SARS-CoV-2 | |
| Mice, Transgenic | |
| HLA-DRB1 Chains | |
| CD4-Positive T-Lymphocytes | |
| Spike Glycoprotein, Coronavirus |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| T32 AI007036 | NIAID NIH HHS | United States | T32AI007036 | PubMed and NIH | NIH RePORTER |
| U01 AI149644 | NIAID NIH HHS | United States | U01AI149644 | PubMed and NIH | NIH RePORTER |
| U01 AI151810 | NIAID NIH HHS | United States | U01AI151810 | PubMed | NIH RePORTER |
| U19 AI142790 | NIAID NIH HHS | United States | U19AI142790 | PubMed and NIH | NIH RePORTER |
References147
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33853928 | SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients. | Sci Immunol | 2021 | https://conductscience.org/library/papers/33853928 | PubMed |
| 2 | 35314848 | Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory. | Nat Immunol | 2022 | https://conductscience.org/library/papers/35314848 | PubMed |
| 3 | 29427907 | Human coronavirus circulation in the United States 2014-2017. | J Clin Virol | 2018 | https://conductscience.org/library/papers/29427907 | PubMed |
| 4 | 35857703 | ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies. | Science | 2022 | https://conductscience.org/library/papers/35857703 | PubMed |
| 5 | 35224466 | No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults. | iScience | 2022 | https://conductscience.org/library/papers/35224466 | PubMed |
| 6 | 32475066 | Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS-CoV-2. | Curr Protoc Microbiol | 2020 | https://conductscience.org/library/papers/32475066 | PubMed |
| 7 | 32668444 | SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. | Nature | 2020 | https://conductscience.org/library/papers/32668444 | PubMed |
| 8 | 34010947 | Diverse functional autoantibodies in patients with COVID-19. | Nature | 2021 | https://conductscience.org/library/papers/34010947 | PubMed |
| 9 | 33331927 | SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein. | Blood | 2020 | https://conductscience.org/library/papers/33331927 | PubMed |
| 10 | 32459916 | Hospitalization and Mortality among Black Patients and White Patients with Covid-19. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32459916 | PubMed |
| 11 | 32979816 | Protective and enhancing interactions among dengue viruses 1-4 and Zika virus. | Curr Opin Virol | 2020 | https://conductscience.org/library/papers/32979816 | PubMed |
| 12 | 36917669 | Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/36917669 | PubMed |
| 13 | 34465633 | Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination. | Science | 2021 | https://conductscience.org/library/papers/34465633 | PubMed |
| 14 | 33457109 | Decoding Covid-19 with the SARS-CoV-2 Genome. | Curr Genet Med Rep | 2021 | https://conductscience.org/library/papers/33457109 | PubMed |
| 15 | 33159009 | Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. | Science | 2020 | https://conductscience.org/library/papers/33159009 | PubMed |
| 16 | 32997649 | Recent endemic coronavirus infection is associated with less-severe COVID-19. | J Clin Invest | 2021 | https://conductscience.org/library/papers/32997649 | PubMed |
| 17 | 33293664 | Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63. | Sci Rep | 2020 | https://conductscience.org/library/papers/33293664 | PubMed |
| 18 | 31075077 | Cross-Protection of Dengue Virus Infection against Congenital Zika Syndrome, Northeastern Brazil. | Emerg Infect Dis | 2019 | https://conductscience.org/library/papers/31075077 | PubMed |
| 19 | 33031744 | A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice. | Cell | 2020 | https://conductscience.org/library/papers/33031744 | PubMed |
| 20 | 37468623 | A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. | Nature | 2023 | https://conductscience.org/library/papers/37468623 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42903838 | Conserved nucleocapsid epitopes induce cross-reactive CD4+ T-cell responses with selective protection against human coronaviruses in mice. | Hlife | 2026 | https://conductscience.org/library/papers/42903838 | PubMed |
| 41295541 | Current Status and Challenges of Vaccine Development for Seasonal Human Coronaviruses. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41295541 | PubMed |
| 41123344 | Development of a cross-protective common cold coronavirus vaccine. | J Virol | 2025 | https://conductscience.org/library/papers/41123344 | PubMed |
| 41012619 | T-Cell Epitope-Based SARS-CoV-2 DNA Vaccine Encoding an Antigen Fused with Type 1 Herpes Simplex Virus Glycoprotein D (gD). | Viruses | 2025 | https://conductscience.org/library/papers/41012619 | PubMed |
| 40910046 | Prepandemic levels of cytokines and immunoglobulins and risk of SARS-CoV-2 infection and COVID-19 in the general population of Barcelona. | Front Public Health | 2025 | https://conductscience.org/library/papers/40910046 | PubMed |
| 40690526 | Population-level toggling of T cell immune escape at human leukocyte antigen anchor residues in SARS-CoV-2 Spike proteins, in an ethnically diverse population region. | PLoS Comput Biol | 2025 | https://conductscience.org/library/papers/40690526 | PubMed |
| 40494917 | T-cell responses induced by SARS-CoV-2 index-virus nanoparticle protein vaccine to the ancestral and omicron variants 6 months following primary vaccination. | Commun Med (Lond) | 2025 | https://conductscience.org/library/papers/40494917 | PubMed |
| 40446030 | Proteomic signatures of corona and herpes viral antibodies identify IGDCC4 as a mediator of neurodegeneration. | Sci Adv | 2025 | https://conductscience.org/library/papers/40446030 | PubMed |
| 40387363 | Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding antibodies. | J Virol | 2025 | https://conductscience.org/library/papers/40387363 | PubMed |
| 40313411 | Phylogenetic and epidemiological insights into centenarians' resilience to COVID-19: exploring the role of past coronavirus pandemics. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40313411 | PubMed |
| 40191213 | Enhanced and long-lasting SARS-CoV-2 immune memory in individuals with common cold coronavirus cross-reactive T cell immunity. | Front Immunol | 2025 | https://conductscience.org/library/papers/40191213 | PubMed |
| 39743545 | The guided fire from within: intratumoral administration of mRNA-based vaccines to mobilize memory immunity and direct immune responses against pathogen to target solid tumors. | Cell Discov | 2025 | https://conductscience.org/library/papers/39743545 | PubMed |
| 39702529 | Co-immunization with spike and nucleocapsid based DNA vaccines for long-term protective immunity against SARS-CoV-2 Omicron. | NPJ Vaccines | 2024 | https://conductscience.org/library/papers/39702529 | PubMed |
| 39625929 | Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice. | PLoS One | 2024 | https://conductscience.org/library/papers/39625929 | PubMed |
| 39353281 | Influence of Th1 versus Th2 immune bias on viral, pathological, and immunological dynamics in SARS-CoV-2 variant-infected human ACE2 knock-in mice. | EBioMedicine | 2024 | https://conductscience.org/library/papers/39353281 | PubMed |
| 39157328 | Bioinformatic elucidation of conserved epitopes to design a potential vaccine candidate against existing and emerging SARS-CoV-2 variants of concern. | Heliyon | 2024 | https://conductscience.org/library/papers/39157328 | PubMed |
| 38966641 | Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming. | Front Immunol | 2024 | https://conductscience.org/library/papers/38966641 | PubMed |
| 38865483 | Heterotypic immunity from prior SARS-CoV-2 infection but not COVID-19 vaccination associates with lower endemic coronavirus incidence. | Sci Transl Med | 2024 | https://conductscience.org/library/papers/38865483 | PubMed |
| 38793729 | Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38793729 | PubMed |
| 38611624 | Long COVID: Long-Term Impact of SARS-CoV2. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/38611624 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38278784
GET https://conductscience.org/api/papers/v1/38278784/authors?page=2